Work Package 1: Service capacity: SmartECG architecture scale-up and validation
Work in WP1 was completed during the first project year.
During the first year, we finalized and tested the system architecture scale-up strategy, based on the evaluation done in the feasibility study. As a result of WP1, we are prepared to support 10.000 end-users. Also, we have a specific step-by-step strategy and all contracts in place for activating necessary infrastructure upgrades at the proper expansion stage. During this work package, we also confirmed that the customer identification and data transferring method for SmartECG software are safe and meet the requirements of national, EU and USA standards. We successfully developed a browser-based ECG user interface for tablet mode and ensured that the user interface is compatible with mobile devices.
Work Package 2: Final product: Ensuring SmartECG interface interoperability and algorithm fine-tuning
The work in WP2 concentrated on finalising the system and device interfaces. The end-result of WP2 was that we have successfully developed SmartECG software for healthcare professionals for viewing and analyzing Holter ECG results.
Work Package 3: Validation and piloting: Ensuring SmartECG clearance to the market
This work package concentrated on validation and testing activities – the end goal of the WP was to ensure clearance to global markets. During the second year, we received the CE certification and also put a lot of focus on collaboration with different piloting partners. The piloting negotiations were successful in Finland and Sweden.
Work Package 4: Commercialisation strategy and plan
WP4 was an on-going for the entire project. By the end of the SmartECG project, we can say that commercialisation activities have run well and successful. The main accomplishments from the second year include continuing the promotion of SmartECG via different PR activities and also attending many conferences and workshops to ensure establishing good contacts. We are prepared for a rapid SmartECG commercialisation and roll-out to market.
